Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
20:59:59 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.6400 CAD | 0.00% |
|
+4.92% | -8.57% |
| 08-05 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| 08-04 | Grown Rogue International Inc., Q2 2026 Earnings Call, Aug 04, 2026 |
| Market Cap | 115M 99.46M 93.24M 85.01M 160M 10.95B 163M 1.1B 429M 5.48B 431M 421M 18.29B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 130M 113M 106M 96.35M 181M 12.41B 184M 1.24B 486M 6.21B 488M 478M 20.73B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 week | +4.92% | ||
| Current month | +10.34% | ||
| 1 month | -1.54% | ||
| 3 months | +30.61% | ||
| 6 months | +23.08% | ||
| Current year | -8.57% |
| 1 week | 0.61 |  | 0.65 |
| 1 month | 0.52 | | 0.67 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.22 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 14/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +4.92% | -1.54% | +178.26% | 115M | |
| -0.18% | -0.45% | -9.89% | -7.24% | 13.37B | |
| -0.16% | +0.04% | -31.70% | -56.19% | 5.06B | |
| -0.55% | -2.17% | +4.13% | +2.05% | 5.01B | |
| +1.91% | +5.17% | +5.88% | -29.83% | 4.16B | |
| +0.19% | -0.22% | -13.96% | -5.79% | 3.66B | |
| -0.75% | -7.72% | -6.65% | -0.32% | 3.44B | |
| +0.78% | -0.39% | -5.34% | +15.75% | 3.39B | |
| +0.82% | +3.69% | -13.70% | -15.03% | 2.48B | |
| -1.47% | +10.38% | +0.21% | -11.36% | 1.79B | |
| Average | +0.06% | +0.82% | -7.26% | +7.03% | 4.25B | |
| Weighted average by Cap. | +0.05% | -0.52% | -8.79% | -11.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.42M 21.95M 20.02M 37.66M 2.58B 38.27M 258M 101M 1.29B 101M 99.23M 4.31B | 32.43M 28.11M 26.35M 24.03M 45.21M 3.09B 45.93M 310M 121M 1.55B 122M 119M 5.17B |
| Net income | -11.3M -9.8M -9.18M -8.37M -15.76M -1.08B -16.01M -108M -42.22M -540M -42.44M -41.52M -1.8B | 1.73M 1.5M 1.41M 1.28M 2.41M 165M 2.45M 16.55M 6.46M 82.64M 6.49M 6.35M 276M |
| Net Debt | 3.7M 3.21M 3.01M 2.74M 5.16M 354M 5.25M 35.44M 13.84M 177M 13.91M 13.61M 590M | 15.3M 13.26M 12.43M 11.34M 21.33M 1.46B 21.67M 146M 57.15M 731M 57.44M 56.19M 2.44B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | CA$0.6400 | 0.00% | 15,800 |
| 12/08/26 | CA$0.6400 | +1.59% | 11,000 |
| 11/08/26 | CA$0.6300 | +1.61% | 9,500 |
| 10/08/26 | CA$0.6200 | +3.33% | 34,500 |
| 07/08/26 | CA$0.6000 | -1.64% | 2,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
